Moldova COVID-19 Employer Resources

  • The first stage of vaccination has begun, vaccines for 20.000 persons have been donated by Romania and the medical personnel have the priority to be vaccinated. Up to 20.000 vaccines will be received soon through COVAX system. Unfortunately, it is a small volume of vaccine for a population of 3,5 million.
  • The Russian Sputnik V vaccine was accepted by the Authority to be delivered through a network of private clinics. In the past this vaccine was continuously rejected by the Authority as not being recognized by the World Health Organization. A large part of population will purchase the available vaccines through a private medical network.
  • A new mutation of the virus was found in Moldova, and the number of infected persons is constantly rising, so the vaccination is of tremendous importance, regardless of its provenance but taking into consideration the efficiency

COVID-19 vaccine considerations for Moldova

  • Can employers mandate the vaccine?
  • Who will control delivery of the vaccine?
    Federal and provincial governments, A network of private clinics has received the authorization to provide vaccination with Sputnik V. This vaccine is not allowed in public health system, as far as this vaccine didn’t get the authorization of WHO.
  • Who covers the cost of the vaccine?
    Public Health service, Employer - sponsored health insurance, Employee
  • Where will people get vaccinated?
    Government designated vaccination locations and Authorized Private clinics.
  • Is there cultural resistance to getting the vaccine?
    A little, because the COVID-19 vaccine is so new

More Information

Ministry of Health of the Government of Republic of Moldavia.


This information is provided by GrECo Group, Asinta's partner in Moldova.

Employee Benefits in Moldova

Get insights on mandatory and common supplementary employee benefits in Moldova.

Learn More

Top 6 Vaccine Considerations

Use our decision matrix to help support your employees.

Learn More

Page last modified: March 4, 2021

The information presented on this site is current as of the date initially posted; and, because matters related to COVID-19, the vaccine, and compliance measures are changing so quickly, it may not be current as of the date you read it. While the information gathered here is from Asinta global partners who are subject matter experts in their respective fields, this information is not meant to be a substitute for individual legal or medical advice, or as a substitute for advice in your specific situation.